Skip to main content

Population Health Management Market to Register a CAGR of an Excellent CAGR of 19.9% USD 91.43 Billion by 2026; Increasing Healthcare Facilities to Bode well for the Market States Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Dec. 01, 2020 (GLOBE NEWSWIRE) — The global population health management market size is predicted to reach USD 91.43 billion by 2026, exhibiting a CAGR of 19.9% during the forecast period. The market size stood at USD 21.40 billion in 2018. The market in North America generated a revenue of USD 13.84 billion in 2018 and is predicted to grow rapidly during the forecast period owing to the advanced healthcare infrastructure and greater adoption of healthcare IT.
KEY INDUSTRY DEVELOPMENTS:February 2020 – Pillo Health announced the launch of their product offering of Pillo Remotely, a population health data and device manager which enables better visibility into home health habits, for better participation of the patients in their treatment plans.December 2019 – Humana and Koninklijke Philips NV announced their participation for the improvement of care provided to high-risk Medicare Advantage members by the implementation of two new programs that support Koninklijke Philips NV’s population health management and remote patient monitoring solutions.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/population-health-management-market-100626
The rising shift from fee-for-service (FFS) to a value-based payment (VBP) in healthcare will have a positive impact on the population health management (PHM) market growth during the forecast period. Moreover, the growing awareness regarding value-based payment (VBP) and its holistic approach, which allows clinical outcomes and reimbursement from insurance companies.Thus, the shift from conventional fee-for-service (FFS) reimbursement to value-based payment (VBP) reimbursement will enable speedy growth of the market in the forthcoming years. In addition, the effective accessibility of population health management over diverse specialties and various healthcare institutions will boost the population health management (PHM) market trends.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit:  https://www.fortunebusinessinsights.com/industry-reports/population-health-management-market-100626
Agreement Between Geisinger and Cerner to Foster GrowthThe focus by key players to launch innovative new population health management software and solutions will create new opportunities for the population health management (PHM) market revenue in the forthcoming years.For instance, in October 2019, Geisinger, a regional health care provider and Cerner, an American supplier of health information technology solutions, services, devices, and hardware announced a ten-year agreement to expand the use of HealtheIntent platform for improved outcomes and diverse delivery network.
Quick Buy –  Population Health Management Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100626
Advanced Healthcare Infrastructure to Support Growth in North AmericaThe market in North America generated a revenue of USD 13.84 billion in 2018 and is predicted to grow rapidly during the forecast period owing to the advanced healthcare infrastructure and greater adoption of healthcare IT.The presence of major market players and their products in the region will aid growth in North America. The rising awareness among the patient population towards population health management and home healthcare will enable growth in North America. The market in Europe and Asia-Pacific is expected to witness steady growth owing to the lower initial adoption and of population health management.
The Report Lists the Key Main Companies in the PHM MarketCerner CorporationAllscripts Healthcare, LLCDeloitte Touche Tohmatsu LimitedGE Healthcare (General Electric Company)International Business Machines Corporation (IBM)Koninklijke Philips N.V.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/population-health-management-market-100626
Global Population Health Management Market Segmentation:By Component•  Software•  ServicesBy Platform• Cloud-based• On-premiseBy End User•  Healthcare Providers•  Healthcare Payers•  OthersBy Geography•  North America (U.S. and Canada)•  Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)•  Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)•  Latin America (Brazil, Mexico, and Rest of Latin America)•  Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/population-health-management-market-100626
SECONDARY DATA SOURCES THAT WE REFER TO:Annual reports, investor presentation, SEC filings, and press releases of companies operating in the marketStudies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.Website, reports, and press releases of end-user facilities – Hospitals, Ambulatory Surgery Centres, ClinicsIndustry journals and paid databases
Have a Look at Related Reports:Hemostats Market Share and Global Trend By Product Type (Active Hemostats, Passive Hemostats, Combination Hemostats), Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery & Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers) and Geography Forecast till 2025Prothrombin Complex Concentrate (PCC) Market Share and Global Trend By Product Type (3-factor PCC, 4-factor PCC), Application (Congenital and Acquired Coagulation Factor deficiency), End User (Hospitals, Ambulatory Surgical Centers) and Geography Forecast till 2025Orphan Drugs Market Share and Global Trend By Therapy Area (Oncology, Blood, CNS, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales) and Geography Forecast till 2025Multiple Sclerosis Drugs Market Share and Global Trend By Drug Class (Immunomodulatory, Immunosuppressant, Interferons, Others), By Route of Administration (Oral, Injection), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Stores), and Geography Forecast till 2026Advanced Wound Dressings Market Share and Global Trend By Product Type (Alginate Dressings, Hydrogel Dressings, Film Dressings, Hydrocolloid Dressings, Antimicrobial Dressings, Foam Dressings), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds), End Users (Hospitals, Clinics, Home Care Settings) and Geography Forecast till 2025
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.308, Supreme Headquarters,Survey No. 36, Baner,Pune-Bangalore Highway,Pune – 411045, Maharashtra, India.
Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: sales@fortunebusinessinsights.comFortune Business Insights™LinkedIn | Twitter | BlogsPress Release: https://www.fortunebusinessinsights.com/press-release/population-health-management-phm-market-9723

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.